We previously observed that when incubated with EVs derived from NLCs and M2-THP1 cells, CLL-B-cells demonstrated enhanced survival, a process already described as dependent on the overexpression of BCL-2 [6]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.